Dr. Bishal Gyawali recaps key findings from ASCO 2025, including compelling new data from the CHALLENGE trial showing that a structured exercise program significantly improves survival in colon cancer patients. He also contrasts this low-cost intervention with high-cost drug therapies and raises important questions about how we define meaningful progress in oncology.